Orencia 125 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FQHZL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,215
Award facts
- Contract value 100% obligated
- $8,215.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,215.15 to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions, reflecting the Defense Logistics Agency's ongoing procurement of specialty pharmaceuticals to support military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support global military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio primarily focused on medical procurement for the Defense Health Agency and other government healthcare systems. The company's competitively awarded contracts demonstrate its established capability to fulfill federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FQHZL?
SPE2DB25FQHZL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FQHZL worth?
The government has obligated $8,215 on SPE2DB25FQHZL.
Is contract SPE2DB25FQHZL an order under another contract?
Yes. SPE2DB25FQHZL is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQHZL competed?
The extent of competition for SPE2DB25FQHZL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award